Bergemann R, Lauterbach K W, Vanscheidt W, Neander K D, Engst R
Institute for Medical Outcome Research, Loerrach, Germany.
Pharmacoeconomics. 1999 Oct;16(4):367-77. doi: 10.2165/00019053-199916040-00005.
The treatment costs for pressure ulcers and venous leg ulcers were estimated based on the hospital administrator's perspective in Germany.
A spreadsheet model using input data from various hospitals in Germany was developed.
Five currently used treatment strategies were analysed: gauze, impregnated gauze, calcium alginate and hydroactive wound dressing with enzymatic ointment.
All cases used for and in the analysis were treated in the inpatient setting (4 hospitals and 120 patients were included).
The outcome distributions were calculated using the Monte Carlo method. For the whole treatment process, the attributable costs for the hospital were calculated for different cases (severity) and all treatment strategies (1997 values). The costs for treatment with gauze were the highest, whereas the costs for treatment with hydroactive wound dressings and enzymatic ointment were the lowest. The relation between personnel and material costs for gauze is approximately 95 to 5% and for hydroactive wound dressings 67 to 33%, respectively. The cost savings per case were between 1196 deutschmark (DM) and DM9826 using hydroactive wound dressings instead of gauze dressings (depending on the severity of the pressure ulcer), and between DM135 and DM677 for venous leg ulcers. The results were robust and did not change in any performed sensitivity analysis (parameter: 'personnel costs per minute', 'time required for changing a wound dressing', 'total number of wound dressing changes').
Despite the higher material costs of the hydroactive wound dressings in combination with enzymatic wound cleaning compared with other wound dressings, they should be recommended for the treatment of pressure ulcers and venous leg ulcers. This therapy alternative brings about significant reductions in total costs for hospitals because of significant reductions in personnel costs and the duration of treatment.
从德国医院管理人员的角度估算压疮和下肢静脉溃疡的治疗费用。
开发了一个使用德国多家医院输入数据的电子表格模型。
分析了五种目前使用的治疗策略:纱布、浸渍纱布、藻酸钙和含酶软膏的水活性伤口敷料。
分析中使用的所有病例均在住院环境中接受治疗(纳入4家医院的120名患者)。
使用蒙特卡罗方法计算结局分布。对于整个治疗过程,计算了不同病例(严重程度)和所有治疗策略(1997年数值)的医院可归因成本。纱布治疗的成本最高,而水活性伤口敷料和含酶软膏治疗的成本最低。纱布的人员成本与材料成本之比约为95%至5%,水活性伤口敷料的这一比例分别为67%至33%。使用水活性伤口敷料而非纱布敷料,每例病例的成本节约在1196德国马克(DM)至9826德国马克之间(取决于压疮的严重程度),下肢静脉溃疡的成本节约在135德国马克至677德国马克之间。结果具有稳健性,在任何进行的敏感性分析(参数:“每分钟人员成本”、“更换伤口敷料所需时间”、“伤口敷料更换总数”)中均未改变。
尽管与其他伤口敷料相比,水活性伤口敷料联合酶促伤口清洁的材料成本更高,但仍应推荐用于治疗压疮和下肢静脉溃疡。这种治疗选择可显著降低医院总成本,因为人员成本和治疗持续时间大幅减少。